For the founders of any startup, the defining moment of success is to have their company go public on NASDAQ. In 2014, six Israeli companies are hoping to live out this dream, raising an aggregate total of $883 million. It looks like going public is the new exit.

Israeli companies are holding IPOs left and right. While the figures are usually all that hit the headlines, Israeli plant genomics company Evogene, which recently raised $84 million on the New York Stock Exchange, told NoCamels what it's really like to go public.